MedTrace Logo

Deployment and Evaluation of Humanoid Robotics in Coalition-Aligned Clinical Care Settings

NCT07214896 · Status: ENROLLING_BY_INVITATION · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 400

Last updated 2025-10-20

No results posted yet for this study

Summary

This clinical trial evaluates the deployment of humanoid robotics in coalition-aligned healthcare settings. The study measures biometric performance, ESG compliance, and operational impact across patient care, sanitation, and intake workflows. Humanoid units are enhanced via biotech integration and compensated through blockchain-based wage tokens. Outcomes will inform coalition governance, wage calibration, and metro-scale deployment strategies.

Conditions

  • Mobility Impairment
  • Clinical Workflow Optimization
  • Sanitation Protocol Compliance
  • ESG-linked Healthcare Robotics Deployment

Interventions

BIOLOGICAL

Skin Cell Dip

Lab-grown keratinocyte dip applied to humanoid units to improve tactile sensitivity and surface regeneration.

BIOLOGICAL

Stem Cell Dip

iPSC-derived neuroblast dip applied to humanoid units to enhance neural responsiveness and adaptive learning.

OTHER

Wage Token Distribution

HumanoidWage (HMW) tokens minted and distributed based on biometric audit scores and ESG task completion.

BEHAVIORAL

ESG Compliance Monitoring, Operational protocol

Real-time tracking of energy usage, sanitation cycles, and carbon offset metrics via coalition dashboard.

Sponsors & Collaborators

  • Truway Health, Inc.

    lead INDUSTRY

Principal Investigators

  • Gavin C Solomon, President & CEO · Truway Health, Inc.

Study Design

Allocation
RANDOMIZED
Purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE
Model
PARALLEL

Eligibility

Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2025-10-06
Primary Completion
2031-10-06
Completion
2031-10-06
FDA Drug
Yes

Countries

  • United States
  • Germany
  • Japan

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07214896 on ClinicalTrials.gov